US Patent Issued to The Trustees of Columbia University in the City of New York, The University of North Carolina at Chapel Hill, Revolution Medicines on June 23 for "MYC amplification drives resistance to pan-RAS inhibitors in pancreatic cancer" (New York, California, North Carolina Inventors)

ALEXANDRIA, Va., July 15 -- United States Patent no. 12,662,707, issued on June 23, was assigned to The Trustees of Columbia University in the City of New York (New York), The University of North Carolina at Chapel Hill (Chapel Hill, N.C.) and Revolution Medicines Inc. (Redwood City, Calif.).

"MYC amplification drives resistance to pan-RAS inhibitors in pancreatic cancer" was invented by Kenneth Paul Olive (New York), Urszula Wasko (New York), Channing Der (Chapel Hill, N.C.), Mallika Singh (Redwood City, Calif.) and Jingjing Jiang (Redwood City, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Methods of treating a tumor in a subject comprising administering to the subject an amount of a RASMULTI inhib...